Syngene International Limited (SYNGENE) - Total Liabilities
Based on the latest financial reports, Syngene International Limited (SYNGENE) has total liabilities worth Rs18.07 Billion INR (≈ $195.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Syngene International Limited to see how much of total assets are deployed in long-term investments.
Syngene International Limited - Total Liabilities Trend (2010–2025)
This chart illustrates how Syngene International Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Syngene International Limited total assets.
Syngene International Limited Competitors by Total Liabilities
The table below lists competitors of Syngene International Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Perpetual Ltd
AU:PPT
|
Australia | AU$1.74 Billion |
|
Guangdong Guangzhou Daily Media Co Ltd
SHE:002181
|
China | CN¥824.39 Million |
|
Sihui Fuji Electronics Technology Co Ltd
SHE:300852
|
China | CN¥911.79 Million |
|
NP3 Fastigheter AB
ST:NP3
|
Sweden | Skr17.22 Billion |
|
Opera Ltd
NASDAQ:OPRA
|
USA | $148.76 Million |
|
Jiangsu Eazytec Co Ltd
SHG:688258
|
China | CN¥697.80 Million |
|
Grg Metrology
SHE:002967
|
China | CN¥2.70 Billion |
|
Gas Malaysia Bhd
KLSE:5209
|
Malaysia | RM2.13 Billion |
Liability Composition Analysis (2010–2025)
This chart breaks down Syngene International Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SYNGENE net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.27 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Syngene International Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Syngene International Limited (2010–2025)
The table below shows the annual total liabilities of Syngene International Limited from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs20.69 Billion ≈ $223.77 Million |
+9.26% |
| 2024-03-31 | Rs18.94 Billion ≈ $204.81 Million |
-14.42% |
| 2023-03-31 | Rs22.13 Billion ≈ $239.33 Million |
-2.35% |
| 2022-03-31 | Rs22.66 Billion ≈ $245.08 Million |
+9.91% |
| 2021-03-31 | Rs20.62 Billion ≈ $222.98 Million |
+3.76% |
| 2020-03-31 | Rs19.87 Billion ≈ $214.90 Million |
+14.52% |
| 2019-03-31 | Rs17.35 Billion ≈ $187.64 Million |
+18.15% |
| 2018-03-31 | Rs14.69 Billion ≈ $158.82 Million |
+7.93% |
| 2017-03-31 | Rs13.61 Billion ≈ $147.15 Million |
+1.80% |
| 2016-03-31 | Rs13.37 Billion ≈ $144.56 Million |
+131.82% |
| 2015-03-31 | Rs5.77 Billion ≈ $62.36 Million |
+8.47% |
| 2014-03-31 | Rs5.32 Billion ≈ $57.49 Million |
+158.56% |
| 2013-03-31 | Rs2.06 Billion ≈ $22.23 Million |
-29.05% |
| 2012-03-31 | Rs2.90 Billion ≈ $31.34 Million |
+2.26% |
| 2011-03-31 | Rs2.83 Billion ≈ $30.65 Million |
-11.02% |
| 2010-03-31 | Rs3.19 Billion ≈ $34.44 Million |
-- |
About Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and anal… Read more